Grant: Collaborative Health Research Projects
University of Toronto
$117,385.00
Biomaterial substrates for xeno- and feeder layer-free culture of human pluripotent stem cells
FY 2015-16
Summary
Pluripotent stem cells are a promising tool for future applications in human therapeutics. Their ability to contribute to
potentially all tissues and organs in the human body makes them highly valuable for tissue engineering, organ replacement,
and pharmaceutical research. The culture conditions in which pluripotent stem cells are derived and maintained still contain
animal or human blood products that are of potential risk for recipients, as they may contain viruses, bacteria or other
harmful bioactive molecules. Our research project will develop new synthetic protein-coated polymers as attachment and
growth matrices for human pluripotent stem cell cultures. These chemically defined substrates will eliminate the risk of
pathogen transmission in subsequent human pluripotent stem cell applications, providing an important step towards safe,
clinical grade culture products for human stem cells. Moreover, our synthetic polymers will be more cost-effective,
standardized and reproducible than existing methods.
Since it is now possible to generate patient-specific stem cell lines, our technologies will assist future personalized therapies
for patients suffering from chronic conditions like arthritis, diabetes, or heart disease. Four out of five Canadians at a risk to
develop degenerative chronic diseases, and therefore our technologies have strong potential to indirectly improve the health
of Canadians.
Canada is among the world leaders in human stem cell research. Our strongly translational research project will be of great
benefit for the Canadian commercial stem cell sector and will train highly qualified personnel with interdisciplinary expertise
and professional skills immediately relevant to Canadas growing biotechnology and regenerative medicine sectors.
Program
Collaborative Health Research Projects
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
478473-2015
Name nom
Simmons, Craig
Department département
Mechanical and Industrial Engineering
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
117385
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Partie
1
Nb partie
3
Application title
Biomaterial substrates for xeno- and feeder layer-free culture of human pluripotent stem cells
Keyword
NSERC
Application summary
Pluripotent stem cells are a promising tool for future applications in human therapeutics. Their ability to contribute to
potentially all tissues and organs in the human body makes them highly valuable for tissue engineering, organ replacement,
and pharmaceutical research. The culture conditions in which pluripotent stem cells are derived and maintained still contain
animal or human blood products that are of potential risk for recipients, as they may contain viruses, bacteria or other
harmful bioactive molecules. Our research project will develop new synthetic protein-coated polymers as attachment and
growth matrices for human pluripotent stem cell cultures. These chemically defined substrates will eliminate the risk of
pathogen transmission in subsequent human pluripotent stem cell applications, providing an important step towards safe,
clinical grade culture products for human stem cells. Moreover, our synthetic polymers will be more cost-effective,
standardized and reproducible than existing methods.
Since it is now possible to generate patient-specific stem cell lines, our technologies will assist future personalized therapies
for patients suffering from chronic conditions like arthritis, diabetes, or heart disease. Four out of five Canadians at a risk to
develop degenerative chronic diseases, and therefore our technologies have strong potential to indirectly improve the health
of Canadians.
Canada is among the world leaders in human stem cell research. Our strongly translational research project will be of great
benefit for the Canadian commercial stem cell sector and will train highly qualified personnel with interdisciplinary expertise
and professional skills immediately relevant to Canadas growing biotechnology and regenerative medicine sectors.